Status:
COMPLETED
Randomised Study of High-flux Haemodialysis and Haemodiafiltration
Lead Sponsor:
NHS Greater Glasgow and Clyde
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The most common forms of renal replacement therapy currently in use are high flux haemodialysis (HF-HD) and haemodiafiltration (HDF). Although these techniques appear similar to the patient, there are...
Eligibility Criteria
Inclusion
- Receiving HF-HD for at least 3 months
- Reliable vascular access (i.e. use of the same fistula, graft or tunnelled central venous catheter for at least 1 month)
- Aged 18 or older
Exclusion
- Currently receiving HDF
- Emergency hospital admissions within the preceding 4 weeks
- Life expectancy less than 6 months
- Neoplasia
- Unable to give informed consent
- Unable to perform QoL questionnaire or self report recovery post-dialysis time
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01862679
Start Date
July 1 2013
End Date
March 1 2014
Last Update
June 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Greater Glasgow andClyde
Glasgow, United Kingdom, G12 0XH